Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

Post time 2022-5-19 17:45:05

journal：New England Journal of Medicine

Authors：Juan P. Frías; Melanie J. Davies; Julio Rosenstock; Federico C. Pérez Manghi; Laura Fernández Landó; Brandon K. Bergman; Bing Liu; Xuewei Cui; Katelyn Brown

Published date：2021-8-5

DOI：10.1056/nejmoa2107519

Article link：http://dx.doi.org/10.1056/nejmoa2107519

Article Source：Massachusetts Medical Society。

Remark：

Post time 2022-5-19 17:45:06

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2022-5-19 17:46:11

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2022-5-19 17:46:24

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2022-5-19 18:02:02

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2022-5-19 18:02:13

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2022-5-19 18:02:22

: This post has been completed
Completed attachments will be deleted within 24 hours.

[NEJM] Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today